KIF18A and colorectal cancer: KIF18A knockdown increased the protein expression of p21, and reduced the protein expression of CDK1 and cyclin B1 in NCI-H747, SW620 and CT26 CIN+ colorectal cancer cells, suggesting that KIF18A inhibition triggered G2/M phase arrest (Fig. 3A).